NeuroOncology Advances

A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma.

ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study.

ICAM-1 和 IL-10 与胶质瘤患者使用 MoCA 测试进行的认知功能障碍相关：来自 NCI 神经肿瘤分部自然史研究的发现

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

癌细胞分泌组的蛋白质诱导弥漫性内生性脑桥胶质瘤的促肿瘤微环境

Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands.

胶质母细胞瘤中 EGFR 共表达和激活的转录组分析揭示了其与配体的关联

Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model.

在免疫功能健全的小鼠神经胶质瘤模型中，对表达 CAR 的 T 细胞、NK 细胞、NKT 细胞和巨噬细胞进行比较评价

Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.

NT-I7（一种长效白细胞介素-7）的 I 期研究，用于治疗高级别胶质瘤患者在接受标准放射治疗和替莫唑胺治疗后出现的严重治疗相关性淋巴细胞减少症

Nuclear NAD(+) synthase nicotinamide mononucleotide adenylyltransferase 1 contributes to nuclear atypia and promotes glioma growth.

核 NAD(+) 合成酶烟酰胺单核苷酸腺苷酰转移酶 1 导致核异型性并促进胶质瘤生长

Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma.

联合抑制 SHP2 可克服 BRAF V600E 驱动的高级别胶质瘤对 1 型 BRAF 抑制剂的适应性耐药性

Inferred developmental origins of brain tumors from single-cell RNA-sequencing data.

从单细胞 RNA 测序数据推断脑肿瘤的发育起源

Evaluating the efficacy of Hip1R, Vimentin, and H3K27me3 as surrogate markers for 1p/19q co-deletion in oligodendrogliomas.

评估 Hip1R、波形蛋白和 H3K27me3 作为少突胶质细胞瘤中 1p/19q 共缺失的替代标志物的有效性